This review highlights the evolutionary conservation and specialized functions of the actinin protein family, detailing how mutations in human ACTN genes lead to specific diseases including cardiomyopathies.
Answers are grounded in this paper and cite their sources.
May inform genetic panels for cardiomyopathies and related traits; leaves open mechanistic studies and clinical translation.
Actinins are one of the major actin cross-linking proteins found in virtually all cell types and are the ancestral proteins of a larger family that includes spectrin, dystrophin and utrophin. Invertebrates have a single actinin-encoding ACTN gene, while mammals have four. Mutations in all four human genes have now been linked to heritable diseases or traits. ACTN1 mutations cause macrothrombocytopenia, a platelet disorder characterized by excessive bleeding. ACTN2 mutations have been linked to a range of cardiomyopathies, and ACTN4 mutations cause a kidney condition called focal segmental glomerulosclerosis. Intriguingly, approximately 16 % of people worldwide are homozygous for a nonsense mutation in ACTN3 that abolishes actinin-3 protein expression. This ACTN3 null allele has undergone recent positive selection in specific human populations, which may be linked to improved endurance and adaptation to colder climates. In this review we discuss the human genetics of the ACTN gene family, as well as ACTN gene knockout studies in several model organisms. Observations from both of these areas provide insights into the evolution and cellular functions of actinins.
No takes yet. Share an insight, caveat, or question.
Murphy et al. (2015) conducted a review in Genetic disorders associated with ACTN mutations. ACTN gene mutations was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: